| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/16/2004 | WO2004056322A3 Antibiotics containing borinic acid complexes and methods of use |
| 09/16/2004 | WO2004050096A3 Phosphoantigens for regulating an immune response |
| 09/16/2004 | WO2004046101A3 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 09/16/2004 | WO2004039803A3 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 09/16/2004 | WO2004012655A3 Anti-microbial compositions and methods of using same |
| 09/16/2004 | WO2004004646A3 O-derivatized nocathiacin derivatives |
| 09/16/2004 | WO2003096989A3 Anti tubercular drug: compositions and methods |
| 09/16/2004 | WO2003096974A3 ORIENTIA TSUTSUGAMUSHI TRUNCATED RECOMBINANT OUTER MENBRANE PROTEIN (r47) AND (r56) VACCINES DIAGNOSTICS AND THERAPEUTICS FOR SCRUB TYPHUS AND HIV INFECTION |
| 09/16/2004 | WO2003095398A3 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 09/16/2004 | WO2003073989A3 Nucleoside 5'-monophosphate mimics and their prodrugs |
| 09/16/2004 | WO2003072553A8 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials |
| 09/16/2004 | WO2003062265A3 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003045228A9 Methods for treating autoimmune disorders, and reagents related thereto |
| 09/16/2004 | WO2003043583A3 Treatment of immunological disorders using anti-cd30 antibodies |
| 09/16/2004 | WO2003026690A9 Incapacitated whole-cell immunogenic bacterial compositions |
| 09/16/2004 | WO2002069691A3 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/16/2004 | US20040181063 such as 1-C-(5-N-benzyloxymethyl-4-methoxy pyrrolo[3,2-d]pyrimidin-7-yl)-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol; potent inhibitors of purine nucleoside phosphorylase and useful for suppressing T-cell function and/or treating and/or preventing infections caused by protozoan parasites |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181037 Phosphatidyl serine receptors and uses thereof |
| 09/16/2004 | US20040181035 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 09/16/2004 | US20040180962 Dosage forms having prolonged active ingredient release |
| 09/16/2004 | US20040180938 More preferred compound is (1Z,3E)-1-methyl-1-(4-carboxyphenyl)-2-methoxycarbonyl-3-(2-methylpyridin-4-yl)aminocarbonyl-4-(3-methoxyphenyl)butadiene; for the treatment of acute coronary symptoms |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | US20040180925 such as (S)-1-[2-(2-Pyrazinylamino)ethylamino]acetyl-2-pyrrolidinecarbonitrile dimethanesulfonate |
| 09/16/2004 | US20040180910 Heterocycle carboxamides as antiviral agents |
| 09/16/2004 | US20040180893 enzymatically or synthetically prepared alpha-hydroxyglycinamide inhibit the replication of HIV in human serum |
| 09/16/2004 | US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/16/2004 | US20040180881 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180871 Anti-inflammatory compositions and methods |
| 09/16/2004 | US20040180858 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 09/16/2004 | US20040180850 Polysaccharides with Helicobacter pylori receptor activity; preventing bacteria adhesion; stabilizing gastrointestinal mucus layer against ulcer causing agents |
| 09/16/2004 | US20040180843 Treatment of helicobacter with isothocyanates |
| 09/16/2004 | US20040180842 antibiotics and antiprotozoa agents |
| 09/16/2004 | US20040180834 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 09/16/2004 | US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis |
| 09/16/2004 | US20040180066 Useful for threapy of pain/inflammation associated with infection caused by herpes virus, especially herpes simplex virus (HSV) and varicella-zoster virus (VZV) |
| 09/16/2004 | US20040180062 Administering by whole-body spray, an effective amount of a vaccine comprising a live avirulent derivative of an enteropathogenic bacteria to the bird |
| 09/16/2004 | US20040180056 Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| 09/16/2004 | US20040180053 Binding protein |
| 09/16/2004 | US20040180046 Bispecific molecules and uses thereof |
| 09/16/2004 | US20040180035 Administering to the mammal (i) an immunoconjugate comprising an antibody binding site capable of binding the preselected cell-type and a cytokine capable of inducing a said immune response against the preselected cell-type, and (ii) an angiogenesis inhibitor to enhance immune response |
| 09/16/2004 | US20040180007 Pharmaceutical chewing gum formulations |
| 09/16/2004 | DE10308632A1 Helicobacter pylori Antibiotikum Helicobacter pylori antibiotic |
| 09/16/2004 | CA2796381A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2517970A1 Bifunctional heterocyclic compounds and methods of making and using the same |
| 09/16/2004 | CA2517706A1 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents |
| 09/16/2004 | CA2517525A1 Posh interacting proteins and related methods |
| 09/16/2004 | CA2517136A1 Composition for treating hepatitis c |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1457202A2 Topical formulation comprising a NSAID, preferably diclofenac, for alleviating pain/inflammation caused by herpes virus infection |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456651A2 Self-assembly molecules |
| 09/15/2004 | EP1456647A2 Methods for identifying and validating potential drug targets--- |
| 09/15/2004 | EP1456411A2 Methods of detecting modification of genetic material |
| 09/15/2004 | EP1456398A2 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna and use of recombinant hpivi in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 09/15/2004 | EP1456396A1 Hybrid glycosylated products and their production and use |
| 09/15/2004 | EP1456383A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/15/2004 | EP1456382A2 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456241A2 Mono-and dual anti-cd4-rantes chemokine/cytokine constructs |
| 09/15/2004 | EP1456230A2 Flavivirus ns1 subunit vaccine |
| 09/15/2004 | EP1456229A2 Method for preparing echinocandin derivatives |
| 09/15/2004 | EP1456221A2 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 09/15/2004 | EP1456214A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456208A1 Pyridoquinoxaline antivirals |
| 09/15/2004 | EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 09/15/2004 | EP1456200A1 Lactams as tachykinin antagonists |
| 09/15/2004 | EP1456171A1 Substituted cyclohexane derivatives |
| 09/15/2004 | EP1456163A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456160A2 Vitamin d analogues |
| 09/15/2004 | EP1455900A1 Methods of treating bacterial infections in dogs and cats |
| 09/15/2004 | EP1455841A2 Osteopontin-related compositions and methods |
| 09/15/2004 | EP1455837A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| 09/15/2004 | EP1455809A2 Inhibitors of hepatitis c virus |
| 09/15/2004 | EP1455804A2 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 09/15/2004 | EP1455801A1 Ribavirin granulate for producing coated tablets |
| 09/15/2004 | EP1455775A2 Methods and compositions for modulating the immune system and uses thereof |
| 09/15/2004 | EP1455772A1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 09/15/2004 | EP1455769A2 Processes for preparing crystalline and amorphous mupirocin calcium |
| 09/15/2004 | EP1455768A1 Respiratory infection prevention and treatment with terpene-containing compositions |
| 09/15/2004 | EP1455766A2 Thymosin alpha 1 peptide/polymer conjugates |
| 09/15/2004 | EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| 09/15/2004 | EP1455757A2 Methods for wet granulating azithromycin |
| 09/15/2004 | EP1455754A2 Pharmaceutical compositions in particulate form |
| 09/15/2004 | EP1455700A2 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 09/15/2004 | EP1455582A1 Adhesion inhibition of fungi |
| 09/15/2004 | EP1455581A2 Inhibition of the asexual reproduction of fungi |
| 09/15/2004 | EP1401421A4 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor |
| 09/15/2004 | EP1395587A4 Process for the preparation of imipenem |
| 09/15/2004 | EP1339420B1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 09/15/2004 | EP1322325A4 Inhibiting hepatitis c virus processing and replication |
| 09/15/2004 | EP1299395B1 Oxazinoquinolones useful for the treatment of viral infections |
| 09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/15/2004 | EP1196408B1 Respiratory syncytial virus replication inhibitors |
| 09/15/2004 | EP1169311A4 Oxazole and thiazole combinatorial libraries |
| 09/15/2004 | EP1140077B1 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |